|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Boehringer Ingelheim Pharmaceuticals |
| Information provided by: | Boehringer Ingelheim Pharmaceuticals |
| ClinicalTrials.gov Identifier: | NCT00076999 |
Purpose
The purpose of this study is to determine the safety and tolerability of liquid formulation tipranavir together with low dose ritonavir in HIV-infected children and adolescents. Additionally, the study will provide information concerning the pharmacologic characteristics of tipranavir in this age group.
| Condition | Intervention | Phase |
|
HIV Infections |
Drug: Tipranavir Drug: Ritonavir |
Phase I Phase II |
| MedlinePlus related topics: | AIDS |
| ChemIDplus related topics: | Ritonavir Tipranavir |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment |
| Official Title: | Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in HIV-Infected Children |
Eligibility
| Ages Eligible for Study: | 2 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA
EXCLUSION CRITERIA
Contacts and Locations| United States, California | |||||
| Childrens Hospital of Los Angeles | |||||
| Los Angeles, California, United States, 90027 | |||||
| Los Angeles County - USC Medical Center | |||||
| Los Angeles, California, United States, 90033 | |||||
| United States, Connecticut | |||||
| Connecticut Children's Medical Center | |||||
| Hartford, Connecticut, United States, 06106 | |||||
| United States, Illinois | |||||
| Children's Memorial Hospital | |||||
| Chicago, Illinois, United States, 60614 | |||||
| United States, Massachusetts | |||||
| UMASS Memorial Medical Center | |||||
| Worcester, Massachusetts, United States, 01655 | |||||
| Baystate Medical Center | |||||
| Springfield, Massachusetts, United States, 01199 | |||||
| United States, Ohio | |||||
| Rainbow Babies and Childrens Hospital | |||||
| Cleveland, Ohio, United States, 44106 | |||||
| United States, Tennessee | |||||
| St. Jude Children's Research Hospital | |||||
| Memphis, Tennessee, United States, 38105 | |||||
| United States, Texas | |||||
| Texas Children's Hospital | |||||
| Houston, Texas, United States, 77030 | |||||
| Puerto Rico | |||||
| San Juan Hospital | |||||
| San Juan, Puerto Rico, 00935 | |||||
| Boehringer Ingelheim Pharmaceuticals |
More Information
| Study ID Numbers: | 1182.14 |
| First Received: | February 9, 2004 |
| Last Updated: | July 2, 2007 |
| ClinicalTrials.gov Identifier: | NCT00076999 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|